Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 820 | 1,120 | 1,305 | 1,262 | 1,112 |
| Cost of Goods | 636 | 717 | 728 | 1,086 | 651 |
| Gross Profit | 184 | 403 | 577 | 176 | 461 |
| Operating Expenses | 2,941 | 2,884 | 3,147 | 2,377 | 3,318 |
| Operating Income | -2,121 | -1,764 | -1,842 | -2,115 | -2,206 |
| Interest Expense | 0 | 0 | 20 | 0 | 352 |
| Other Income | 93 | 37 | 74 | -6 | -17 |
| Pre-tax Income | -2,028 | -1,727 | -1,788 | -2,121 | -2,575 |
| Net Income Continuous | -2,028 | -1,727 | -1,788 | -2,121 | -2,575 |
| Net Income | $-2,028 | $-1,727 | $-1,788 | $-2,121 | $-2,575 |
| EPS Basic Total Ops | -0.51 | -0.44 | -0.07 | -1.94 | -3.64 |
| EPS Basic Continuous Ops | -0.51 | -0.44 | -0.08 | -1.94 | -3.64 |
| EPS Diluted Total Ops | -0.51 | -0.44 | -0.07 | -1.94 | -3.64 |
| EPS Diluted Continuous Ops | -0.51 | -0.44 | -0.08 | -1.94 | -3.64 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.44 | N/A | -1.94 | -3.64 |
| EBITDA(a) | $-2,068 | $-1,711 | $-1,789 | $-2,063 | $-2,153 |